Alternatives to regimens with mifepristone and a prostaglandin analog for medical abortion
emerged because of the need for accessible, effective, and safe options in areas of the …

Medical abortion offers an important alternative to surgical abortion for women with early
pregnancies who wish to avoid a surgical procedure. More than 3 million women worldwide …

Objective: To review the literature on medical abortion in early pregnancy. Data Sources: I
performed a MEDLINE search, supplemented by bibliographies of articles and textbooks. In …

Social and political constraints have prohibited the use of mifepristone in most countries. As
a result, researchers, clinicians, and women throughout the world have pushed for the …

OBJECTIVE: To review published reports of first-trimester medical abortion regimens that do
not include mifepristone. METHODS: Reports listed in Pubmed and Medline on prospective …

Objective: The purpose of this study was to evaluate the efficacy, side-effect profile, and
follow-up rates in women who obtain a medical abortion in a nonresearch setting. Study …

Medical abortion using mifepristone and a prostaglandin analogue is a highly effective
option for early abortion. Since the clinical introduction of mifepristone to the world in 1988 …

The phrase medical abortion commonly refers to use of medications up to 63 days' gestation
to effect abortion, although some regimens are effective beyond 63 days. Medical abortion …

Multiple clinical studies demonstrate the efficacy of medical abortion with mifepristone or
methotrexate followed by a prostaglandin analogue. However, assessing predictors of …

A regimen that includes mifepristone in a dosage of 200 mg administered orally, followed by
misoprostol in a dosage of 800 mcg administered vaginally, is highly effective for medical …